AccessHope and Johns Hopkins Medicine have partnered to increase access to oncology expertise and research to optimize cancer treatment plans across the U.S. through expert case reviews.
Researchers at the Johns Hopkins Kimmel Cancer Center’s Sol Goldman Pancreatic Cancer Research Center have developed a 3D genomic profiling technique to identify small precancerous lesions in the pancreas—called pancreatic intraepithelial neoplasias—that lead to one of the most aggressive, deadly pancreatic cancers.
